FDA
approval
· 2015-03-27
FDA Approved: REYATAZ — Supplemental Application (E.R. Squibb & Sons, L.L.C.)
Summary
The FDA approved a supplemental application for REYATAZ (atazanavir) submitted by E.R. Squibb & Sons, L.L.C. This action typically updates labeling or expands i…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for REYATAZ (ATAZANAVIR)